Navigation Links
Isis Reports Financial Results and Highlights for First Quarter of 2008
Date:5/12/2008

- Conference Call Webcast Monday, May 12, 08:30 a.m. EDT at

http://www.isispharm.com

CARLSBAD, Calif., May 12 /PRNewswire-FirstCall/ -- Isis Pharmaceuticals, Inc. (Nasdaq: ISIS) today announced its financial results for the quarter ended March 31, 2008. The Company finished the quarter with a pro forma net operating loss (NOL) of $5.1 million, excluding compensation expense related to stock options, compared to a pro forma NOL of $18.5 million in the first quarter of 2007. This 73% reduction in NOL was driven primarily by significantly increased revenue from Isis' successful partnering activities. On a GAAP basis, Isis recorded a 2008 loss from operations for the quarter of $8.8 million, compared to $20.9 million in the first quarter of 2007, a 58% decrease. Isis remains on track to meet its 2008 guidance for a NOL, excluding non-cash compensation expense, of less than $15 million.

"Isis ends the first quarter of 2008 in the strongest financial position in our history, and we are on track to meet our NOL and cash guidance for the year. As a result of recent transactions, both Ibis and Regulus are fully funded and are tangible examples of the value being created through our satellite company strategy," said B. Lynne Parshall, Chief Operating Officer and Chief Financial Officer of Isis. "In addition to the significant cash position with which we ended 2007, we have received $192 million in cash so far in 2008 to end the quarter with nearly $340 million."

Results of Operations

The 58% decrease in the Company's loss from operations for the first quarter of 2008 compared to the first quarter of 2007 was primarily a result of a si
'/>"/>

SOURCE Isis Pharmaceuticals, Inc.
Copyright©2008 PR Newswire.
All rights reserved

Page: 1 2 3 4 5 6 7 8 9 10 11 12 13 14

Related medicine news :

1. New Study Reports High Injury Rates for Hotel Workers, Even Higher Rates for Women and Nonwhites
2. Haemacure Reports Third Quarter 2007 Results
3. First-Ever List of the 5,000 Fastest-Growing Businesses Reports Total Revenue of $194.5 Billion
4. Consumer Reports Analysis: Drugs for Nerve Pain, Fibromyalgia Effective, But Not Always Best
5. MDS Reports Third Quarter 2007 Results
6. Allied Healthcare Reports Strong Fourth Quarter, Flat Net Income for Fiscal 2007 vs. 2006
7. AtriCure Reports First Human Implant of the Cosgrove-Gillinov Left Atrial Appendage Occlusion System
8. NMHC Reports Fourth Quarter and Fiscal Year 2007 Financial Results
9. Blue Cross and Blue Shield of Florida Reports Eighteenth Consecutive Year of Positive Performance
10. ReBuilder Medical Technologies, Inc. Reports International Sales Expansion
11. AdCare Health Systems, Inc. Reports Discontinuation of Definitive Merger Agreement with Family Home Health Services, Inc.
Post Your Comments:
*Name:
*Comment:
*Email:
(Date:3/28/2015)... Las Vegas, NV (PRWEB) March 28, 2015 ... option for patients with Type V AC joint injuries, ... The study, presented today at the American Orthopaedic Society ... military personnel returned to duty faster when surgery was ... 24 patients, with 7 receiving surgical treatment and 17 ...
(Date:3/28/2015)... 28, 2015 Aureus Medical Group ... including physical therapy jobs, has announced that it ... Physical Therapy Association Annual Conference to be held ... Hotel in Columbus, OH. , The OPTA ... exhibits with products and services. , Representatives ...
(Date:3/28/2015)... 2015 ARDX will sponsor the 7th Annual ... at the Chesapeake Conference Center in Chesapeake, Virginia. Each ... event for women in the Hampton Roads region. The ... Women’s Lives. Women grow stronger through sharing their stories ... This year the WWC™ theme is T-talk where we will ...
(Date:3/27/2015)... 2015 The Monogamy Method ... Samantha Sanderson and Jason Rogers has just been released ... attention. The commotion surrounding the course's launch has caught ... publish an in-depth review of the new program. , ... in their lives suddenly start pulling away or expressing ...
(Date:3/27/2015)... 27, 2015 The federal court overseeing ... the statin medication increases the risk that a patient ... Motion to Dismiss four individual cases that had been ... Order issued in the U.S. District Court, District of ... the dismissals were warranted because the plaintiffs in those ...
Breaking Medicine News(10 mins):Health News:For Type V AC Joint Injuries, Early Surgery May Not Be the Best Approach 2Health News:Healthcare Staffing Leader, Aureus Medical Group, to Exhibit at the Ohio Physical Therapy Association Annual Conference 2Health News:The Monogamy Method - Review Of Samantha Sanderson & Jason Rogers' Relationship Program Released 2Health News:Lipitor Lawsuits Move Forward in Federal Multidistrict Litigation, as Court Rules on Pfizer’s Motion to Dismiss Certain Cases 2Health News:Lipitor Lawsuits Move Forward in Federal Multidistrict Litigation, as Court Rules on Pfizer’s Motion to Dismiss Certain Cases 3
... May 27 The Food Allergy &,Anaphylaxis Network (FAAN) ... N.Y., on May 31, 2008. Many families struggle with,how ... attendees have,been living with food allergies for years or ... Conference attendees will learn tips and strategies for ...
... closer to that of roses or bananas? Weizmann Institute scientists ... first time that smells can be mapped and the relative ... in Nature Methods, may help scientists to unravel the basic ... enabling odors to be digitized and transferred via computer in ...
... Please join the Urban League of,Philadelphia for FREE Open ... and teens, ages 19 and under, in,Pennsylvania,s Children,s Health Insurance ... office of the Urban League of Philadelphia, 121,S. Broad Street ... building on:, Wednesday, May 28th, 6pm - 8pm ...
... current recommended daily allowance (RDA) of vitamin D for ... reveals that children may need and can safely take ... in The Endocrine Societys Journal of Clinical Endocrinology & ... health of children worldwide and may have other long-term ...
... China, May 27 /Xinhua-PRNewswire-FirstCall/ -- Mindray,Medical International ... developer, manufacturer,and marketer of medical devices worldwide, ... and co-chief executive officer, Mr. Minghe,Cheng, Mindray,s ... Ms.,May Li, Mindray,s investor relations manager, will ...
... May 27, 2008 Three researchers who ... as part of the institutions acclaimed Endowed Scholars ... biomedical scientists nationwide who today were named Howard ... assistant professor of immunology, Dr. Youxing Jiang, assistant ...
Cached Medicine News:Health News:FAAN Brings 'Food Allergies: Living and Learning' to Annual Food Allergy Conference in New York 2Health News:FAAN Brings 'Food Allergies: Living and Learning' to Annual Food Allergy Conference in New York 3Health News:Weizmann Institute scientists produce the first smell map 2Health News:Does Your Child Have Health Insurance? Urban League of Philadelphia Announces Free Open Houses for CHIP Enrollment 2Health News:Current vitamin D recommendations fraction of safe, perhaps essential levels for children 2Health News:Mindray to Attend Goldman Sachs 29th Annual Global Healthcare Conference 2Health News:UT Southwestern faculty members named Howard Hughes investigators 2Health News:UT Southwestern faculty members named Howard Hughes investigators 3Health News:UT Southwestern faculty members named Howard Hughes investigators 4
(Date:3/27/2015)... 2015   Hospira, Inc. (NYSE: ... the world,s leading provider of injectable drugs and ... evaluation of biosimilarity of its proposed biosimilar, Epoetin ... (FDA) conditionally approved name of RETACRIT™, compared to ... study data were presented at the National Kidney ...
(Date:3/27/2015)... 27, 2015 Concord Medical Services Holdings ... CCM ), a leading specialty hospital management solution ... radiotherapy and diagnostic imaging centers in ... a purchase agreement under which Concord Medical Services ... the Company, agreed to acquire the Fortis Surgical ...
(Date:3/26/2015)... , March 26, 2015 "Whether it,s our ... one day." In a single sentence, ... scientific officer at Pfizer,s Centers for Therapeutic Innovation ... scientists fueling progress at America,s biopharmaceutical companies. ... side-by-side with academia, patient foundations and the National Institutes ...
Breaking Medicine Technology:Hospira Clinical Data Shows Proposed Biosimilar, Epoetin Hospira, Demonstrates Pharmacokinetic And Pharmacodynamic Equivalence Compared To Amgen's Epogen 2Hospira Clinical Data Shows Proposed Biosimilar, Epoetin Hospira, Demonstrates Pharmacokinetic And Pharmacodynamic Equivalence Compared To Amgen's Epogen 3Concord Medical Announces Acquisition of Fortis Surgical Hospital in Singapore 2Concord Medical Announces Acquisition of Fortis Surgical Hospital in Singapore 3Collaboration for Cures: Teaming Up to Advance Science and Save Lives 2
Intended for the quantitative determination of glucose in biological fluids. Reaction: endpoint. Wavelength: 340 nm. Linearity: 800 mg/dL (44.4 mmol/L)....
Intended for the quantitative determination of glucose in serum. Reaction: endpoint. Wavelength: 500 nm. Linearity: 500 mg/dL (27.8 mmol/L)....
For the quantitative determination of Glucose in serum. Endpoint Reaction Product measured at 520 nm. Linearity: 500 mg/dl....
For the quantitative determination of Glucose in serum. Endpoint reaction (NAD -> NADH) measured at 340 nm. Linearity: 600 mg/dl. Liquid working reagent prepared with simple 1:9 dilution....
Medicine Products: